Literature DB >> 16251215

Type and frequency of mutations in the LRRK2 gene in familial and sporadic Parkinson's disease*.

Daniela Berg, Katherine J Schweitzer, Petra Leitner, Alexander Zimprich, Peter Lichtner, Petra Belcredi, Theresa Brüssel, Claudia Schulte, Sylvia Maass, Thomas Nägele, Zbigniew K Wszolek, Thomas Gasser.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16251215     DOI： 10.1093/brain/awh666

Source DB:  PubMed          Journal:  Brain        ISSN： 0006-8950            Impact factor:   13.501


× No keyword cloud information.
  67 in total

1.  Kinetic, mechanistic, and structural modeling studies of truncated wild-type leucine-rich repeat kinase 2 and the G2019S mutant.

Authors:  Min Liu; Stephanie Kang; Soumya Ray; Justin Jackson; Alexandra D Zaitsev; Scott A Gerber; Gregory D Cuny; Marcie A Glicksman
Journal:  Biochemistry       Date:  2011-10-07       Impact factor: 3.162

2.  The LRRK2 G2019S mutant exacerbates basal autophagy through activation of the MEK/ERK pathway.

Authors:  José M Bravo-San Pedro; Mireia Niso-Santano; Rubén Gómez-Sánchez; Elisa Pizarro-Estrella; Ana Aiastui-Pujana; Ana Gorostidi; Vicente Climent; Rakel López de Maturana; Rosario Sanchez-Pernaute; Adolfo López de Munain; José M Fuentes; Rosa A González-Polo
Journal:  Cell Mol Life Sci       Date:  2012-07-08       Impact factor: 9.261

3.  Effective long-term subthalamic stimulation in PARK8 positive Parkinson's disease.

Authors:  Sorin Breit; T Wächter; D Schmid-Bielenberg; D Weiss; P Leitner; T Nägele; D Freudenstein; T Gasser; R Krüger
Journal:  J Neurol       Date:  2010-02-23       Impact factor: 4.849

Review 4.  The pleomorphic pathology of inherited Parkinson's disease: lessons from LRRK2.

Authors:  Vincenzo Bonifati
Journal:  Curr Neurol Neurosci Rep       Date:  2006-09       Impact factor: 5.081

5.  Leucine-rich repeat kinase 1: a paralog of LRRK2 and a candidate gene for Parkinson's disease.

Authors:  Julie P Taylor; Mary M Hulihan; Jennifer M Kachergus; Heather L Melrose; Sarah J Lincoln; Kelly M Hinkle; Jeremy T Stone; Owen A Ross; Robert Hauser; Jan Aasly; Thomas Gasser; Haydeh Payami; Zbigniew K Wszolek; Matthew J Farrer
Journal:  Neurogenetics       Date:  2007-01-16       Impact factor: 2.660

6.  The Roc domain of leucine-rich repeat kinase 2 is sufficient for interaction with microtubules.

Authors:  Payal N Gandhi; Xinglong Wang; Xiongwei Zhu; Shu G Chen; Amy L Wilson-Delfosse
Journal:  J Neurosci Res       Date:  2008-06       Impact factor: 4.164

7.  LRRK2 Gly2385Arg mutation and clinical features in a Chinese population with early-onset Parkinson's disease compared to late-onset patients.

Authors:  Daniel Kam Yin Chan; Ping Wing Ng; Vincent Mok; Jonas Yeung; Zhi Ming Fang; Raymond Clarke; Edward Leung; Lawrence Wong
Journal:  J Neural Transm (Vienna)       Date:  2008-06-04       Impact factor: 3.575

8.  Characterization of the Roco protein family in Dictyostelium discoideum.

Authors:  Wouter N van Egmond; Peter J M van Haastert
Journal:  Eukaryot Cell       Date:  2010-03-26

Review 9.  Parkinson's disease.

Authors:  Timothy R Mhyre; James T Boyd; Robert W Hamill; Kathleen A Maguire-Zeiss
Journal:  Subcell Biochem       Date:  2012

10.  LRRK2 in Parkinson's disease - drawing the curtain of penetrance: a commentary.

Authors:  Rejko Krüger
Journal:  BMC Med       Date:  2008-11-05       Impact factor: 8.775
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.